Dyskeratosis Congenita (DC) Registry: identification of new features of DC

被引:130
作者
Knight, S
Vulliamy, T
Copplestone, A
Gluckman, E
Mason, P
Dokal, I
机构
[1] Hammersmith Hosp, ICSM, Dept Haematol, London W12 0NN, England
[2] Derriford Hosp, Dept Haematol, Plymouth PL6 8DH, Devon, England
[3] Hop St Louis, Dept Haematol, Paris, France
基金
英国惠康基金;
关键词
bone marrow failure syndrome; dyskeratosis congenita; X-linked;
D O I
10.1046/j.1365-2141.1998.01103.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dyskeratosis congenita (DC) is an inherited disorder characterized by skin pigmentation, nail dystrophy and mucosal leucoplakia. In 1995 a Dyskeratosis Congenita Registry was established at the Hammersmith Hospital. In the 46 families recruited, 76/83 patients were male, suggesting that the major form of DC is X-linked. As well as a variety of noncutaneous abnormalities, the majority (93%) of patients had bone marrow (BM) failure and this was the principal cause (71%) of early mortality In addition to BM hypoplasia, some patients also developed myelodysplasia and acute myeloid leukaemia. Pulmonary abnormalities were present in 19% of patients. In affected females the phenotype was less severe. Some female carriers of X-linked DC had clinical features. Carriers of X-linked DC showed skewed X-chromosome inactivation patterns (XCIPs), suggesting that cells expressing the normal DC allele have a growth/survival advantage over cells that express the mutant allele. Linkage analysis in multiplex families confirmed that the DKC1 gene, responsible for the X-linked form of DC, is located within Xq28 and facilitated its positional cloning. The high incidence of BM failure in association with a wide range of somatic abnormalities together with the ubiquitous expression of DKC1 suggest that, as well as having a critical role in normal haemopoiesis, this gene has a key role in normal cell biology.
引用
收藏
页码:990 / 996
页数:7
相关论文
共 22 条
  • [1] LATE VASCULAR COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION FOR DYSKERATOSIS-CONGENITA
    BERTHOU, C
    DEVERGIE, A
    DAGAY, MF
    SONSINO, E
    SCROBOHACI, ML
    LOIRAT, C
    GLUCKMAN, E
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 79 (02) : 335 - 344
  • [2] Dyskeratosis congenita with pigmentation, dystrophia unguis and leukokeratosis oris
    Cole, HN
    Rauschkolb, JE
    Toomey, J
    [J]. ARCHIVES OF DERMATOLOGY AND SYPHILOLOGY, 1930, 21 (01): : 71 - 95
  • [3] Molecular biology of Fanconi anemia: Implications for diagnosis and therapy
    DAndrea, AD
    Grompe, M
    [J]. BLOOD, 1997, 90 (05) : 1725 - 1736
  • [4] Devriendt K, 1997, AM J HUM GENET, V60, P581
  • [5] Dyskeratosis congenita: An inherited bone marrow failure syndrome
    Dokal, I
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (04) : 775 - 779
  • [6] DYSKERATOSIS-CONGENITA IS A CHROMOSOMAL INSTABILITY DISORDER
    DOKAL, I
    LUZZATTO, L
    [J]. LEUKEMIA & LYMPHOMA, 1994, 15 (1-2) : 1 - 7
  • [7] DOKAL I, 1992, BLOOD, V80, P3090
  • [8] DYSKERATOSIS-CONGENITA
    DRACHTMAN, RA
    ALTER, BP
    [J]. DERMATOLOGIC CLINICS, 1995, 13 (01) : 33 - 39
  • [9] Engman M F., 1926, Arch Belg Dermatol Syphiligr, V13, P685
  • [10] DYSKERATOSIS-CONGENITA - UNUSUAL PRESENTING FEATURES WITHIN A KINDRED
    FORNI, GL
    MELEVENDI, C
    JAPPELLI, S
    RASOREQUARTINO, A
    [J]. PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1993, 10 (02) : 145 - 149